Gemfibrozil

규격

25812-30-0CAS 번호

247-280-2EC 번호

5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acidIUPAC 명칭

C15H22O3화학식

250.33 g/mol분자량

gemfibrozil; 25812-30-0; 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid; Lopid; Lipur; Jezil; CI-719; Gemfibrozilo; Gemlipid; Gemfibrozilum; Pentanoic acid, 5-(2,5-dimethylphenoxy)-2,2-dimethyl-; 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid; Gen-Fibro; DTXSID0020652; 2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure; CI 719; 2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure; NSC-757024; Valeric acid, 2,2-dimethyl-5-(2,5-xylyloxy)-; Gemfibrosil; Q8X02027X3; DTXCID20652; CHEBI:5296; Lopid R; ApoGemfibrozil; GenGemfibrozil; Genlip; NuGemfibrozil; Apo Gemfibrozil; Gen Gemfibrozil; Nu Gemfibrozil; Novo Gemfibrozil; PMS Gemfibrozil; Gemfibrozil, SBPA; Gemfibrozil, GenRX; Bayvit, Gemfibrozilo; Gemfibrozil, Healthsense; CI719; Emfib; RefChem:57800; C10AB04; 247-280-2; 657-339-8; Decrelip; MFCD00079335; Bolutol; Apo-Gemfibrozil; Gemfibrozil (Standard); Cholespid; Gemfibril; Gemfibromax; Fibratol; Fibrocit; Lipazil; Litarek; Trialmin; Ausgem; Pilder; CHEMBL457; 2,2-Dimethyl-5-(2,5-dimethylphenoxy)pentanoic acid; MLS000028421; Renabrazin; Clearol; Elmogan; Fetinor; Gemnpid; Innogen; Ipolipid; Lanaterom; Lifibron; Lipigem; Lipizyl; Lipozid; Micolip; Normolip; Progemzal; Reducel; Regulip; Sinelip; Synbrozil; Taborcil; Tentroc; Brozil; Lipira; Gozid; Hidil; Gemd; WL-Gemfibrozil; Gevilon Uno; Low-Lip; 5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid; 5-[(2,5-dimethylphenyl)oxy]-2,2-dimethylpentanoic acid; Gem-S; NCGC00016794-09; SMR000058393; CAS-25812-30-0; Gemfibrozilum [INN-Latin]; Gemfibrozilo [INN-Spanish]; Organolipid; Innogem; CCRIS 318; Lopid (TN); TEVA-A; SR-01000000056; EINECS 247-280-2; BRN 1881200; Gemcor; Gemfibrozil (JAN/USP/INN); Hipolixan;; Gemfibrozil CRS; Lipozid;; Gemcor;; UNII-Q8X02027X3; HSDB 7735; Emfib;; Lipur;; Lopid;; 4TX; Gemfibrozil [USAN:USP:INN:BAN]; Prestwick_637; Gemfibrozil (Lopid); Spectrum_000825; CPD000058393; GEMFIBROZIL [MI]; 114413-98-8; Opera_ID_1658; Prestwick0_000214; Prestwick1_000214; Prestwick2_000214; Prestwick3_000214; Spectrum2_001097; Spectrum3_000440; Spectrum4_000562; Spectrum5_000750; Spectrum5_001991; GEMFIBROZIL [INN]; GEMFIBROZIL [JAN]; GEMFIBROZIL [HSDB]; GEMFIBROZIL [IARC]; GEMFIBROZIL [USAN]; GEMFIBROZIL [VANDF]; SCHEMBL4813; GEMFIBROZIL [MART.]; BSPBio_000227; BSPBio_002060; GEMFIBROZIL [USP-RS]; GEMFIBROZIL [WHO-DD]; KBioGR_000964; KBioSS_001305; 2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeric Acid; MLS001055364; MLS006011850; DivK1c_000138; SPECTRUM1500313; SPBio_001174; SPBio_002148; BPBio1_000251; CI-7; GTPL3439; orb1225491; orb1308681; orb3025505; SCHEMBL9481043; Gemfibrozil, analytical standard; SCHEMBL29398115; HMS500G20; HY-B0258R; KBio1_000138; KBio2_001305; KBio2_003873; KBio2_006441; KBio3_001280; GEMFIBROZIL [ORANGE BOOK]; NINDS_000138; GEMFIBROZIL [EP MONOGRAPH]; GLXC-07494; HMS1568L09; HMS1920B07; HMS2090K14; HMS2091H11; HMS2095L09; HMS2230H24; HMS3259M12; HMS3655C06; HMS3712L09; HMS5079L18; Pharmakon1600-10500313; GEMFIBROZIL [USP MONOGRAPH]; HY-B0258; MSK10081; Tox21_110613; Tox21_201997; Tox21_302784; BBL010807; BDBM50110590; CCG-40111; DL-414; EBC-06088; NSC757024; s1729; SBB012457; STK618740; AKOS001606691; Gemfibrozil for system suitability CRS; Tox21_110613_1; AB03034; AC-4225; DB01241; FD23652; KS-5192; NC00565; NSC 757024; IDI1_000138; NCGC00016794-01; NCGC00016794-02; NCGC00016794-03; NCGC00016794-04; NCGC00016794-05; NCGC00016794-06; NCGC00016794-07; NCGC00016794-08; NCGC00016794-10; NCGC00016794-11; NCGC00016794-13; NCGC00016794-14; NCGC00016794-20; NCGC00022722-03; NCGC00022722-04; NCGC00022722-05; NCGC00022722-06; NCGC00022722-07; NCGC00256601-01; NCGC00259546-01; ST072198; SY052512; Gemfibrozil 100 microg/mL in Acetonitrile; SBI-0051391.P003; AB00052003; CS-0694895; G0368; G1749; NS00010281; SW196802-3; EN300-97098; C07020; D00334; D83091; AB00052003-15; AB00052003-16; AB00052003_17; AB00052003_18; F054267; Q384295; SR-01000000056-3; SR-01000000056-4; SR-01000000056-6; SR-01000000056-7; 2,2-Dimethyl-5-(2,5-dimethylphenoxy)-pentanoic acid; 2,2-DIMETHYL-5-(2,5-XYLYLOXY) VALERIC ACID; BRD-K11129031-001-05-1; BRD-K11129031-001-26-7; BRD-K11129031-001-27-5; Z1259021151; Gemfibrozil, British Pharmacopoeia (BP) Reference Standard; Gemfibrozil, European Pharmacopoeia (EP) Reference Standard; Gemfibrozil, United States Pharmacopeia (USP) Reference Standard; Gemfibrozil, Pharmaceutical Secondary Standard; Certified Reference Material; Gemfibrozil for system suitability, European Pharmacopoeia (EP) Reference Standard동의어